![Karen Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Smith
Direktor/Vorstandsmitglied bei
SKYE BIOSCIENCE, INC.
Vermögen: 194 188 $ am 31.07.2026
Profil
Dr. Karen L. Smith ist Chief Medical Officer bei Emergent BioSolutions, Inc. und unabhängiges Verwaltungsratsmitglied bei Antares Pharma, Inc. sowie unabhängiges Verwaltungsratsmitglied bei Sangamo Therapeutics, Inc. und Acceleron Pharma, Inc. Sie ist Mitglied des Board of Directors bei Antares Pharma, Inc. und Sangamo Therapeutics, Inc. und Acceleron Pharma, Inc. Dr. Smith war zuvor als President & Chief Executive Officer bei Medeor Therapeutics, Inc. beschäftigt, als Chief Executive Officer bei Eliminate Cancer, Inc. und als Director & Vice President bei Celator Pharmaceuticals, Inc, ein Non-Executive Director bei Forward Pharma A/S, ein Chief Medical Officer & EVP-Research & Development bei Jazz Pharmaceuticals Plc, ein SVP-Global Medical Affairs & Head-Dermatology bei Allergan, Inc. ein Head-External Medical Relations bei AstraZeneca LP, ein Head-US Clinical Operations bei Bristol Myers Squibb Co. und ein Chief Executive Officer bei Boron Molecular Ltd. Außerdem war sie Vorstandsmitglied bei Sucampo Pharmaceuticals, Inc. Sie erhielt ihren Bachelor-Abschluss von der Curtin University of Technology, einen Graduiertenabschluss von der University of Salford, einen MBA von der University of New England (Australien), einen Doktortitel von der University of Warwick und einen Doktortitel von der University of Western Australia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.04.2025 | 12’672 ( 0.01% ) | 188 559 $ | 31.07.2026 | |
| 20.04.2026 | 77’100 ( 0.02% ) | 5 628 $ | 31.07.2026 | |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 | |
| 24.06.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Karen Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.06.2018 |
| EMYRIA LIMITED | Direktor/Vorstandsmitglied | 29.11.2021 |
| SKYE BIOSCIENCE, INC. | Direktor/Vorstandsmitglied | 02.07.2024 |
| CONTEXT THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 04.09.2024 |
Ehemalige bekannte Positionen von Karen Smith
| Unternehmen | Position | Ende |
|---|---|---|
| TOUE BIOPAR | Direktor/Vorstandsmitglied | 01.10.2023 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 |
| QUINCE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 |
| ANTARES PHARMA, INC. | Direktor/Vorstandsmitglied | 24.05.2022 |
| EMERGENT BIOSOLUTIONS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2021 |
Ausbildung von Karen Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
31
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 31 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Salford
 University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boron Molecular Ltd.
 Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Produces and distributes chemicals and compounds to the pharmaceutical and biotechnology industries | Process Industries |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New England (Australia)
 University of New England (Australia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Humanetics Corp.
 Humanetics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology, inflammatory diseases & biodefense drugs | Health Technology |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Curtin University of Technology
 Curtin University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emyria Ltd.
 Emyria Ltd. Packaged SoftwareTechnology Services Develops patient-centric care model technology | Technology Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Eliminate Cancer, Inc. | |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
